SCHEMBL6994470

SCHEMBL6994470

CCOC(=O)c1cc(C)c(CC[C@@H]2CO2)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
GAA P10253 4/20 0.40
HPGD P15428 3/20 0.40
KDM4E B2RXH2 3/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
MAPT P10636 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
GLA P06280 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TP53 P04637 2/20 0.37
ALOX15 P16050 2/20 0.37
MAPK1 P28482 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
TSHR P16473 2/20 0.36
HSD17B10 Q99714 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8685218 0.84 HTR7 (0.36) ALDH1A1GAAHPGDKDM4ENPC1
SCHEMBL6994700 0.80 HDAC3 (0.47) ALDH1A1GAAHPGDKDM4ENPC1
SCHEMBL6994696 0.80 HDAC3 (0.47) ALDH1A1GAAHPGDKDM4ENPC1
SCHEMBL6919868 0.75 HDAC3 (0.43) ALDH1A1GAAHPGDKDM4ENPC1
SCHEMBL7831758 0.75 TDP1 (0.39) ALDH1A1GAAHPGDKDM4ENPC1
SCHEMBL8362199 0.73 HDAC3 (0.40) ALDH1A1GAAHPGDKDM4ENPC1
SCHEMBL6996548 0.73 HDAC3 (0.40) ALDH1A1GAAHPGDKDM4ENPC1
SCHEMBL6739730 0.71 PTPN2 (0.46) ALDH1A1GAAHPGDKDM4ENPC1
SCHEMBL12438331 0.71 ALDH1A1 (0.57) ALDH1A1GAAHPGDKDM4ENPC1
SCHEMBL8686598 0.71 MAPT (0.35) ALDH1A1GAAHPGDKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846111-B1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-5981748-A Synthesis of optically pure compounds useful as GARFT inhibitors and their intermediates AGOURON PHARMACEUTICALS, INC. (US) 1999-11-09 US disclosed
EP-0846111-A1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMACEUTICALS, INC. (US) 1998-06-10 EP disclosed
WO-1996040674-A1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMACEUTICALS, INC. (US) 1996-12-19 WO disclosed